J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on May 9, 2003.
Copyright © 2003 by The Physiological Society
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
550/1/305    most recent
2003.042648v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kemppainen, J.
Right arrow Articles by Zierath, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kemppainen, J.
Right arrow Articles by Zierath, J. R.

Received March 6, 2003
Accepted after revision March 9, 2003

Insulin signalling and resistance in patients with chronic heart failure

Jukka Kemppainen1, Hiroki Tsuchida2, Kira Stolen1, Hakan Karlsson3, Marie Björnholm3, Olli J. Heinonen4, Pirjo Nuutila5, Anna Krook3, Juhani Knuuti1, and Juleen R. Zierath6*

1 Turku PET Centre, University of Turku, Turku, Finland
2 Department of Surgical Sciences, Karolinska Hospital, Stockholm, Sweden
3 Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
4 Paavo Nurmi Centre, Sports and Exercise Medicine Unit, Department of Physiology, Turku, Finland
5 Turku PET Centre, University of Turku, Turku, Finland, and Department of Medicine, University of Turku, Turku, Finland.
6 Professor of Physiology, Department of Clinical Physiology, Section for Integrative Physiology, Karolinska Institutet, von Eulers väg 4, II, SE-171 77 Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: Juleen.Zierath{at}fyfa.ki.se.

We investigated whether insulin resistance in patients with chronic heart failure (CHF) is associated with impaired insulin signalling in skeletal muscle and whether exercise training would lead to an improvement in insulin signalling, concomitant with enhanced insulin action. Fourteen men with CHF due to idiopathic dilated cardiomyopathy, with mild-to-moderate limitation of physical activity and a left-ventricular ejection fraction of less than 45 %, were studied before and after either a 5 month exercise training programme (n = 7) or standard care (n = 7). Seven healthy men participated as controls. Whole-body insulin-stimulated glucose uptake was determined by the euglycaemic hyperinsulinaemic clamp technique and skeletal muscle biopsy samples were obtained before and after the insulin infusion for insulin signalling measurements. Insulin-stimulated glucose uptake was 20 % lower in CHF patients versus healthy subjects. Physiological hyperinsulinaemia increased tyrosine phosphorylation of insulin receptor substrate (IRS)-1 by ~2.5-fold, IRS-1-associated phosphatidylinositol 3-kinase (PI-3-kinase) activity by ~2-fold and Akt (protein kinase B) phosphorylation by ~3-fold, with similar responses between healthy subjects and CHF patients. Insulin-mediated glucose uptake was not altered in patients after standard care, whereas exercise training elicited a 25 % increase in glucose uptake. Neither standard care nor exercise training altered insulin-stimulated tyrosine phosphorylation of IRS-1, IRS-1-associated PI-3-kinase activity or Akt phosphorylation. In conclusion, the CHF patients demonstrated impaired insulin-stimulated glucose uptake, despite normal signal transduction in skeletal muscle at the level of IRS-1, PI-3-kinase and Akt. Of clinical relevance is the finding that exercise training improves glucose uptake. However, these changes in insulin action after exercise training appear to be independent of enhanced insulin signalling at the level of IRS-1, PI-3-kinase or Akt.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. M. Witteles and M. B. Fowler
Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 93 - 102.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ashrafian, M. P. Frenneaux, and L. H. Opie
Metabolic Mechanisms in Heart Failure
Circulation, July 24, 2007; 116(4): 434 - 448.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. J. Murray, C. A. Lygate, M. A. Cole, C. A. Carr, G. K. Radda, S. Neubauer, and K. Clarke
Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart
Cardiovasc Res, July 1, 2006; 71(1): 149 - 157.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Liao, S. Takashima, N. Maeda, N. Ouchi, K. Komamura, I. Shimomura, M. Hori, Y. Matsuzawa, T. Funahashi, and M. Kitakaze
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
Cardiovasc Res, September 1, 2005; 67(4): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. C. Sasso, O. Carbonara, R. Nasti, R. Marfella, K. Esposito, P. Rambaldi, L. Mansi, T. Salvatore, R. Torella, and D. Cozzolino
Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects
Eur. Heart J., June 2, 2005; 26(12): 1205 - 1212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 The Physiological Society.